Conning Inc’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-2,592
Closed -$476K 493
2021
Q2
$476K Sell
2,592
-258
-9% -$47.4K 0.01% 289
2021
Q1
$436K Sell
2,850
-270
-9% -$41.3K 0.01% 310
2020
Q4
$487K Sell
3,120
-129
-4% -$20.1K 0.02% 287
2020
Q3
$372K Buy
3,249
+20
+0.6% +$2.29K 0.01% 319
2020
Q2
$362K Buy
3,229
+1
+0% +$112 0.01% 309
2020
Q1
$290K Sell
3,228
-103
-3% -$9.25K 0.01% 320
2019
Q4
$360K Buy
3,331
+50
+2% +$5.4K 0.01% 345
2019
Q3
$321K Sell
3,281
-109
-3% -$10.7K 0.01% 382
2019
Q2
$444K Sell
3,390
-610
-15% -$79.9K 0.01% 325
2019
Q1
$541K Buy
4,000
+40
+1% +$5.41K 0.02% 329
2018
Q4
$386K Sell
3,960
-940
-19% -$91.6K 0.01% 379
2018
Q3
$681K Sell
4,900
-390
-7% -$54.2K 0.02% 317
2018
Q2
$657K Sell
5,290
-90
-2% -$11.2K 0.02% 334
2018
Q1
$600K Buy
5,380
+250
+5% +$27.9K 0.02% 347
2017
Q4
$613K Sell
5,130
-290
-5% -$34.7K 0.02% 358
2017
Q3
$760K Sell
5,420
-350
-6% -$49.1K 0.03% 315
2017
Q2
$702K Sell
5,770
-40
-0.7% -$4.87K 0.03% 334
2017
Q1
$704K Sell
5,810
-120
-2% -$14.5K 0.03% 325
2016
Q4
$726K Buy
5,930
+390
+7% +$47.7K 0.03% 320
2016
Q3
$679K Buy
5,540
+150
+3% +$18.4K 0.03% 322
2016
Q2
$629K Buy
5,390
+10
+0.2% +$1.17K 0.03% 327
2016
Q1
$749K Buy
5,380
+10
+0.2% +$1.39K 0.03% 294
2015
Q4
$1.02M Sell
5,370
-220
-4% -$42K 0.04% 253
2015
Q3
$874K Sell
5,590
-370
-6% -$57.9K 0.04% 262
2015
Q2
$1.08M Buy
5,960
+220
+4% +$39.8K 0.04% 256
2015
Q1
$995K Hold
5,740
0.04% 250
2014
Q4
$1.06M Sell
5,740
-140
-2% -$25.9K 0.05% 234
2014
Q3
$975K Buy
5,880
+670
+13% +$111K 0.05% 242
2014
Q2
$814K Sell
5,210
-300
-5% -$46.9K 0.04% 274
2014
Q1
$838K Buy
5,510
+340
+7% +$51.7K 0.05% 262
2013
Q4
$688K Buy
5,170
+1,020
+25% +$136K 0.04% 269
2013
Q3
$482K Buy
4,150
+520
+14% +$60.4K 0.04% 297
2013
Q2
$335K Buy
+3,630
New +$335K 0.03% 352